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THE EFFECTS OF QUERCETIN ON CYCLING TIME TRIAL 
PERFORMANCE 
 
Douglas Van Pelt Jr., M.S. Kin. 
The University of Texas at Austin, 2012 
Supervisor: Edward F. Coyle 
 
Quercetin is a flavonoid found in commonly consumed fruits and vegetables that has 
exhibited powerful antioxidant and anti-inflammatory properties in rodents and in vitro.  In 
humans, the ergogenic effects of antioxidant supplementation on exercise performance and 
adaptations are still equivocal and need to be further investigated.  A powerful antioxidant such 
as quercetin may inhibit the high levels of oxidative stress associated with the high volume and 
intensity of exercise training seen with trained individuals.  
 
 PURPOSE: To determine the effect of 28 days of daily quercetin supplementation on cycling 
time trial performance and the associated exercise performance variables.   
 
METHODS: Thirteen trained cyclists (VO2peak 58.8 ± 3.9 ml/kg/min) were recruited for this 
study from the University of Texas at Austin and the local Austin, Texas community and 
participated in this placebo controlled, randomized, crossover designed study.  After initial 
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assessment of baseline data (VO2peak, lactate threshold, and two familiarization time trials), 
participants began daily supplementation of either an antioxidant supplement containing vitamins 
and quercetin (Q-VIT: 1000mg quercetin, 820mg Vitamin C, 40mg Vitamin B3) or the same 
vitamin supplement without quercetin (VIT: 820mg Vitamin C, 40mg Vitamin B3).  A simulated 
time trial using an electromagnetically braked cycle ergometer in which subjects had to complete 
a set amount of work (kJ) as fast as possible was performed on the last day of supplementation.  
Measured performance variables included: time to completion, average power output, average 
oxygen consumption (VO2), Respiratory Exchange Ratio (RER), gross mechanical efficiency 
(GE), heart rate (HR), and rating of perceived exertion (RPE). 
 
RESULTS: Quercetin had no effect on HR, RER, power output, or RPE.  There was also no 
difference in time to complete the time trial between treatments.  However, an approximately 
~2% higher, but not significantly different, VO2 during Q-VIT supplementation significantly 
lowered the GE compared to VIT (Q-VIT: 20.49 ± 0.26 % and 19.94 ± 0.33 %; VIT: 20.9 ± 0.24 
% and 20.37 ± 0.33 %; p < .01) at 15 and 30 min respectively. 
 
CONCLUSION: Chronic supplementation for 28 days with a quercetin based antioxidant 
supplement lowered cycling gross efficiency in well trained cyclists, but it did not affect 
performance time.  The results of the current study suggest that chronic supplementation with 
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In an attempt to improve human performance, exercise physiologists and athletes have 
experimented with a plethora of ergogenic aids.  Recently, there has been surge of research into 
naturally occurring substances that may not only provide clinical health benefits, but also induce 
positive changes in exercise performance and training adaptations.  Common plant-derived 
substances provide a safe, easily accessible, and less expensive alternative to preventing disease, 
maintaining health, and possibly increasing mental and physical performance. Epidemiological 
data suggests evidence that diets rich in fruits and vegetables can lower the incidence of some 
Cardiovascular Disease risk factors due to the high concentration of polyphenolic compounds in 
the diet[1].  Flavonoids are a well-defined group of polyphenolic compounds that show potential 
for use in the treatment, prevention, and attenuation of disease through multiple actions, 
including possible anti-oxidant and anti-inflammatory activities, and have been the recent focus 
of clinical and performance investigations.  Specifically, there has been a large interest in the 
potential health and exercise performance benefits of quercetin, a common flavonoid found in 
grapes, apples, cherries, onions, citrus fruits, broccoli, and tea [2].   The flavonoid quercetin has 
been associated with numerous potential health benefits in rodents and in vitro including anti-
viral[3], hepatoprotective, antifibrogenic[4], antiatherogenic[5], anti-inflammatory[6], anti-
apoptotic, and potent antioxidant capabilities[7].   Furthermore, quercetin feeding in mice has 
indicated that quercetin may induce increased aerobic endurance capacity and wheel running 
activity through proliferation of mitochondrial mRNA, proliferator-activated receptor-ϒ 
coactivator (PGC-1α), and sirtuin 1 (SIRT 1)[8].  In vitro observations have also led researchers 
to believe that there may be stimulatory effects of quercetin on the central nervous system 
similar to caffeine, that may have the potential to improve human exercise performance [9].   
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Recent research has focused on the seemingly more promising potential quercetin may have in 
reducing the oxidative stress induced by high intensity exercise. 
 The combination of potent antioxidant and anti-inflammatory mechanisms have not only 
created interest into the potential health benefits of flavonoids in prevention and treatment of 
disease, but have also initiated investigations regarding Quercetin’s potential as an ergogenic aid 
to improve athletic performance in humans.  Current research is difficult to interpret in relation 
to human exercise performance as there have been a variety of results and discussions presented 
thus far [10, 11].  However, current data suggests that quercetin is a modest ergogenic aid in 
untrained [12, 13] and possibly trained individuals [14].  We hypothesize that the powerful 
antioxidant properties of quercetin will improve exercise performance in trained cyclists during a 















REVIEW OF LITERATURE 
 The following literature review will discuss the flavonoid quercetin and its associated 
properties in cell culture, animal, and human experimental trials.  Specifically, the review will 
focus on the effects of exercise on oxidative stress and the proposed mechanism by which 
quercetin can improve the physiological response to this stress; therefore, potentially improving 
exercise performance.  Studies that have evaluated the effect of quercetin based supplements on 
exercise performance will be analyzed. 
 
Exercise and Oxidative Stress 
 Exercise and the inherent associated muscular contractions induces oxidative stress 
through an increase in the production of free radicals [15, 16].  Muscle tissue, xanthine oxidase, 
NAD(P)H oxidase, oxygen within the mitochondria, the release of radicals by macrophages 
and/or neutrophils recruited to repair damaged tissue, contribute to the generation of free radicals 
[17, 18]. The term free radical refers to reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) that include oxygen or nitrogen as the reactive center. Known ROS and RNS 
include, but are not limited to, superoxide, hydrogen peroxide, hydroxyl radicals, singlet oxygen, 
nitric oxide, peroxynitrite, and hyperchlorite [19].  These molecules have an unpaired valence 
electron that makes them highly reactive and volatile to surrounding cells and tissues.  The 
subsequent increase in free radicals above the resting levels created as a by-product of cellular 
respiration leads to a disruption of redox signaling and molecular damage [20, 21].  This 
disruption leads to a series of disturbances that increase muscular fatigue, muscular damage, 
4 
 
DNA damage, and peroxidation of lipid membranes, thus effecting the functioning and recovery 
of damaged tissues and cells [18, 22-24].    
 During exercise, especially high intensity aerobic exercise, there are a large amount of 
free radicals produced by the process of aerobic respiration within the mitochondria.  The 
oxidative stress from these free radicals reduces the efficiency of the electron transport chain 
(ETC) and therefore reduce the efficiency of NADH:NAD
+
 cycling [25, 26].  In turn, the 
efficiency of ATP production is reduced.  The free radicals also have detrimental effects on the 
tricarboxylic acid  (TCA) cycle by inhibiting the actions of enzymes such as α-ketoglutarate 
dehydrogenase (KGDH) and succinate dehydrogenase (SDH) [27].  Supplementation with an 
antioxidant such as quercetin may have the potential to mitigate the disruption of ATP 
production and assist in the maintenance of energy efficiency during exercise. 
However, there are investigations and discussions contrasting the evidence that the 
exercise induced increases in oxidative stress are completely detrimental.  There appears to be an 
optimal level of oxidative stress necessary for some cellular and bodily functions to function 
appropriately.  Reid et al. [23] has shown in vitro that muscular force and fatigability were 
improved with the appropriate levels of reactive oxygen species (ROS).    However, during an 
intense exercise bout, the large increase in oxidative stress may then become detrimental to the 
contractility of the muscle fibers. 
 Furthermore, an increase in oxidative stress seems necessary to induce favorable 
adaptations of the body’s endogenous antioxidant defense system.  Ji et al.[28] examined the 
effects of ROS on pathways involved in the activation of nuclear factor kappa-B (NF-КB) and 
MAP kinases within the muscle cell and suggested that the pathways initiated by oxidative stress 
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are essential for the body to produce advantageous adaptations pertaining to endogenous 
antioxidants and cytoprotective proteins. There are beneficial endogenous adaptations regarding 
the protection of cellular redox homeostasis that occur following an acute bout of exercise, 
especially through the activation of NF-КB [29, 30].  Blockage of RNS production attenuates up-
regulation of superoxide dismutase, an important endogenous antioxidant, along with eNOS and 
iNOS [31].  Preventing oxidative stress during an exercise bout prevents not only the production 
of an improved endogenous protection of oxidative stress but can limit acute exercise 
adaptations. Regular exercise training produces advantageous adaptations essential for improved 
oxidative stress protection [32, 33].  The accumulation of the acute exercise response appears to 
induce favorable protective, chronic improvements in protection against high levels of exercise 
induced oxidative stress.  Most evidence suggests that there needs to be the appropriate balance 
between antioxidant capacity and oxidative stress.  The question remains whether chronic or 
acute supplementation of exogenous antioxidants is detrimental or beneficial to human exercise 
performance and human exercise adaptations.  
Exercise and Inflammation 
 The immune system responds to strenuous exercise and instigates the release of pro- and 
anti-inflammatory cytokines following an exercise bout [34].  Plasma cytokines shown to 
increase during or after an exercise bout include IL-6, IL-10, IL-8, IL-1ra, granulocyte colony 
stimulating factor (G-CSF), C Reactive Protein (CRP), monocyte chemoatractic protein (MCP-
1), and tumor necrosis factor alpha (TNF-α) [35].   Elevations in these cytokines after exercise 
are considered normal; however chronic elevations lead to detrimental health outcomes and 
increased sickness, especially with pro-inflammatory cytokines such as IL-6 and CRP.   
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 A relationship exists between oxidative stress and the inflammatory process.  There are 
intricate redundant cellular pathways mediated by the increase in oxidative stress seen with 
exercise and the production of oxidative stress from macrophages and neutrophils [17].  After an 
intense exercise bout, a large increase in oxidative stress may increase cellular damage, thereby 
increasing inflammation at the site of injury.  The resulting macrophage and neutrophil invasion 
can then increase oxidative stress and cytokine signaling in a cycle of response to the exercise 
stress.  Supplementation with an antioxidant may prevent the overabundance of oxidative stress; 
therefore, systemic inflammation may be lower after the intense exercise bout. 
Quercetin and an Antioxidant and Anti-inflammatory Agent  
 As mentioned, quercetin has potent antioxidant and anti-inflammatory effects in vitro due 
to its chemical structure[2, 36, 37].  Multiple hydroxyl groups on the molecule allow for it to be 
a potent electron acceptor.  The hypothesis of many physiologists is that the antioxidant and anti-
inflammatory capabilities of quercetin may provide a buffer against excess oxidative stress and 
immune response to acute bouts of exercise or high volumes of strenuous exercise training.  By 
attenuating the stress response, a faster recovery of performance may be incurred and allow for 
greater training adaptations or acute exercise performance.  The efficiency of ATP production 
may also be augmented by the prevention of excess oxidative stress and allow for an improved 
exercise performance during the exercise bout. 
Bioavailability of Quercetin 
 Typical intake of flavonoids in the human diet can vary greatly depending on the 
location, demographics, supplementation, and activity level of the population studied: The range 
of typical daily intake can vary from an estimated 5 – 230mg/day [38, 39].  Large scale 
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epidemiological studies support the availability of quercetin in human plasma and serum when 
volunteers were supplemented with doses ranging from 50-1000mg/day.  Quercetin serum and 
plasma levels rose in a direct dose dependent manner [40, 41].  Jin et al. [41] reported that the net 
increase in blood was 332 and 516 micrograms/L, respectively, for the 500 and 1,000 mg/d dose.  
However, the levels of quercetin within the plasma varied greatly among the population with no 
relationship to demographic or lifestyle factors [41].     
 The chemical transformation and alterations of quercetin that occur in the intestinal 
mucosa of humans may contribute greatly to its absorption into human plasma.  Absorption 
seems to be greatly facilitated in combination with its conjugation with a sugar group [42].  The 
glucosidated form has a greater capacity for absorption then the commonly found aglycone form 
found in fruits and vegetables [43].  Strong arguments have also been made for an increased 
bioavailability of quercetin through vitamin “cocktails”: a mix of vitamins and minerals that may 
be beneficial in the absorption of quercetin as the bioavailibilty of quercetin aglycone alone may 
not exhibit the same effects in vivo due to changes in absorption and chemical structure [37].  
Without appropriate sugars, vitamins, or fatty acids, quercetin may undergo conjugation in the 
intestinal mucosa and liver that may weaken its anti-oxidant and anti-inflammatory effects [37, 
44, 45].  There is still more work needed to investigate whether there can be direct associations 
made between the in vitro studies that greatly support a multitude of actions of quercetin and the 
associated changes that may occur on the physical and chemical structure of quercetin upon 
absorption in the intestinal mucosa.  It may need to be administered with an appropriate mixture 




Quercetin and Exercise Performance in Rodents 
 A large interest in the potential effects of quercetin on human exercise performance has 
arisen from not only the in vitro studies that have shown numerous potential health benefits, but 
also the potent effects seen in mice.  Davis et al. [8] examined the effects of 7 days of quercetin 
feedings on markers of mitochondrial biogenesis in skeletal muscle and brain and the associated 
effects on exercise endurance performance.   No exercise training programs were implemented 
on the mice so that the potential benefits of only quercetin ingestion on fitness and endurance 
capacity of the mice were examined.  After 7 days of the quercetin treatment, the mice on 
quercetin treatment exhibited increased mitochondrial DNA, PGC-1α mRNA, expression of 
PGC-1α, SIRT 1, and cytochrome c concentration within the brain and skeletal muscle.  These 
biochemical markers are well established adaptations exemplifying an increase in the metabolic 
pathways responsible for the creation of new mitochondria; one of the main adaptations that 
occur in skeletal muscle in response to exercise training to increase exercise capacity [46, 47].  
The changes in the markers of mitochondrial biogenesis were associated with an increase in 
endurance performance and increased voluntary wheel running activity versus the placebo 
controlled group mice [8].  The benefit that quercetin elicited suggest that the in vitro benefits 
may transfer into a biological system and provide substantial improvements in endurance 
exercise performance independent of exercise training.  
Quercetin and Exercise Performance in Humans 
Chronic Supplementation Improving Performance 
 The aforementioned evidence from Davis et al. [8] and a host of in vitro studies suggest 
that quercetin might have the potential to be a substantial ergogenic aid for human exercise 
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performance; specifically, it may have protective effects against the high levels of oxidative 
stress experienced during strenuous aerobic exercise: There may even be potential for positive 
changes in exercise capacity and performance independent of exercise training.  However, 
human experiments utilizing quercetin in exercise performance trials have only raised more 
questions rather than elucidate its effectiveness in exercise performance.  The evidence that is 
presented from in vitro studies and rodents does not translate into definitive improvements in 
exercise capacity in humans.  Current evidence on quercetin’s influence on human exercise is 
inconclusive thus far. 
 A study in humans by MacRae et al.[14] added quercetin to an antioxidant cocktail and 
cyclists ingested 600mg/day for 6 weeks and compared their performance to a placebo 
supplementation.  They found that although performance was improved compared to a baseline 
practice trial, the addition of quercetin, did not improve performance compared to the antioxidant 
without quercetin.   
 More recently, Davis et al. [12] performed a placebo controlled, double blind, crossover 
study and had twelve untrained subjects ingest 500mg/day for 7 days in vitamin cocktail and 
compared changes in VO2max and endurance capacity.  The untrained subjects showed 
significant improvements in VO2max and time to fatigue while supplementing with quercetin 
versus placebo[12].  However, there were no analyses of plasma or muscle tissue to assess 
possible mechanisms behind these changes or those seen in the trained cyclists from MacRae et 
al. [14]. 
 A more comprehensive cross-sectional design by Nieman et al. examined changes in 
human exercise performance with quercetin supplementation in untrained subjects [13].  Twenty 
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six untrained individuals ingested 1000mg/day Quercetin for 2 weeks and placebo for 2 weeks.  
At the end of each supplementation period the subjects performed a time trial in which they 
attempted to run the farthest distance possible on a treadmill.  Subjects showed a small, but 
significant increase in the amount of distance covered on the treadmill during the quercetin trial.  
Muscle tissue analysis of markers of improved aerobic capacity showed small non-significant 
elevations in mRNA for PGC-1α, SIRT1, cytochrome c, and citrate synthase [13].  Although the 
findings were small and the mRNA data were insignificant, it leads to possible questions as to 
whether a longer supplementation period may have produced significant data.  As discussed 
earlier, MacRae et al.[14] reported improved performance in trained cyclists utilizing a 6 week 
supplementation period, yet, only one week of supplementation was enough to elicit significant 
changes in VO2max in untrained subjects in the crossover design by Davis et al [12].   
 The improvements in performance in both untrained and trained individuals with a 
variety of supplementation periods gives some evidence, although unclear, that quercetin may be 
an effective ergogenic aid for increasing human aerobic exercise performance. 
Chronic Supplementation Without Improvement in Performance 
 In contrast to Davis et al.[12], Ganio et al. [48] reported that 5 days of quercetin 
supplementation did not raise VO2max in 11 untrained men and women.  Although the 
supplementation period was 2 days less then Davis et al, a very similar design resulted in no 
effects on VO2max.  Of interest is the method in which the quercetin was orally delivered.  Davis 
et al. [12] mixed quercetin in a vitamin enriched Tang solution while Ganio et al. [48] used food 
bars that contained quercetin.  Perhaps the bioavailability of the flavonoid differed among the 
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studied groups caused by differences in metabolic transformation of the quercetin molecule [37, 
45]. 
 Another investigation of short term feeding of quercetin by Cureton et al. [49] showed no 
effects of the supplementation on performance in 30 untrained but recreationally active 
participants.  Time of supplementation varied from 9-16 days with 1000mg/day of quercetin 
mixed in a sports hydration beverage.  Subjects cycled for 1 hour at 50% VO2 max, then 
performed a 10 minute cycling bout in which as much work was performed as possible.  This 
design is similar to the type of protocol utilized by Nieman et al [13] by assessing the maximal 
amount of work that can be completed after a submaximal exercise session.   Opposite of 
Nieman et al [13], Cureton et al. [49] was unable to find a difference in the work performed 
between the quercetin and placebo trials. After cycling testing, subjects performed isometric 
strength tests of the knee extensors and revealed no differences when comparing the quercetin 
supplementation to the placebo [49].   
 Additional negative findings regarding the flavonoid’s effects on human exercise 
performance is a study that used 40 trained cyclists in a double-blind, cross sectional, placebo 
controlled investigation that attempted to elucidate quercetin’s effects on exercise performance.  
In 2 of the 3 primary evaluations, the primary outcome was not exercise performance, per se, but 
measurements were taken to investigate the effect of 3 weeks of quercetin on 3 days of cycling at 
57% of VO2max for 3 hours each day [50, 51].  Quercetin exhibited no influence on exercise-
induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA after 3 weeks of 
supplementation [50].  After 6 weeks of supplementation, there were no differences in any 
markers of oxidative stress or total antioxidant status before, during, and after the exercise bout 
[51].  The study administered quercetin in doses of 1000mg/day in a vitamin enriched Tang 
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mixture.   Dumke et al. [52] examined performance parameters using the same study design by 
analyzing heart rate(HR), respiratory exchange ratio, oxygen consumption (VO2), cadence, 
power output, substrate utilization, and cycling gross efficiency.  No differences were observed 
between quercetin and placebo trials regarding the performance data [52].  Although these results 
may provide insight into quercetin’s lack of efficacy on exercise induced inflammatory and 
oxidative response, the exercise bout employed may also not be an adequate or appropriate for 
making claims on the possible effects the flavonoid may have on exercise endurance 
performance.  Other performance tests such as time trials may be a more appropriate method for 
assessing quercetin’s performance effects on trained cyclists [53].   
 Nieman et al [44] employed the same exercise protocol as previously described [50] to 
investigate quercetin’s influence on exercise induced acute inflammatory response and markers 
of mitochondrial biogenesis.  Thirty-nine trained cyclists supplemented for 2 weeks on placebo, 
quercetin, or quercetin with epigallocatechin 3-gallate (EGCG).  No markers of mitochondrial 
biogenesis were elevated, however, there were significantly lower levels of CRP, IL-6, and IL-10 
after exercise in the quercetin with EGCG group immediately following exercise [44].  The 
combination of the quercetin with EGCG may have improved the absorption of quercetin and 
worked in a synergistic manner to improve the anti-inflammatory effects.  No effects on the 
markers of mitochondrial proliferation may be due to the use of trained individuals that possibly 
are closer to their highest potential of mitochondria; untrained individuals may be more sensitive 
to the actions of quercetin on SIRT1 and PGC-1α. 
 The previously described studies have mostly had a primary focus on endurance exercise 
performance.  Abbey et al [54] considered the effect quercetin may have on the maintenance of 
repeated sprint performance; an important factor in high caliber performance during many sports 
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games such as soccer.   Fifteen recreationally active young adult men participated in the 
crossover, placebo controlled experiment and supplemented with 1000mg/day of quercetin for 
one week.  No differences were seen in the maintenance of sprint performance or levels of 
xanthine oxidase and IL-6 in the quercetin group compared to placebo [54].  Abbey et al had 
hypothesized that the possible actions on the adenosine receptors may play a role in maintaining 
sprinting performance.  Bigelman et al. [55] had also examined the effects of 6 weeks of 
quercetin supplementation on various modalities of exercise performance in ROTC cadets 
progressing through the rigors of military training and observed no differences in exercise 
performance or improvement when compared to the placebo. 
Acute Supplementation 
 Although the primary focus of most exercise experiments in human models have been 
related to chronic supplementation of quercetin, there have been some investigations into the 
effect of acute supplementation on exercise.  Cheuvront et al [56] examined a large dose of 
2000mg quercetin on cycling performance during heat stress compared to caffeine and placebo.  
There was no effect of quercetin on cycling performance.  However, there was no effect of the 
caffeine on performance despite a large amount of literature supporting the helpful ergogenic 
effect of caffeine on endurance performance [57, 58].  The dosage of caffeine administered (9 
mg/kg) has been proven to have positive ergogenic effects on exercise performance [58].  
Nonetheless, heat stress has also been shown to nullify the potential benefits of caffeine on 
endurance performance [59].  It is difficult to interpret if the quercetin had no stimulatory effect 




 The potential antioxidant, anti-inflammatory, and immune-modulating influence of a 
single dose of a quercetin based supplement on an acute bout of exercise was examined by 
Konrad et al. in a crossover designed study on 20 endurance trained runners [60].  A mixture of 
1000mg quercetin, 120mg EGCG, and other vitamins provided no benefit to the post-exercise 
immune changes or inflammation.  While the primary outcome of this study was not 
performance, per se, it contributes evidence that quercetin may not alter the immune or oxidative 
stress incurred with exercise, or there are mechanisms unique to chronic supplementation that 
makes quercetin elicit progressive effects on adaptation to exercise training. 
 There have also been investigations into the effects of chronic supplementation with 
quercetin on immune perturbations and inflammation following the western states endurance run.  
This race is a 160 km race that places a large oxidative stress on the participating racers.  No 
effects of the supplementation were found for performance, immune perturbations, or acute 















 Endurance-trained male (n = 11) and female (n = 2) cyclists (age 30.1 ± 7.1 y, body mass 
67.8 ± 10.81 kg, height 173.41 ± 9.15 cm, VO2max 58.83 ± 3.93 ml/kg/min) were recruited for 
this study from the University of Texas at Austin and local Austin, Texas community.  A trained 
cyclist was defined as an individual that regularly competes in cycling racing and competitions 
and had a minimum VO2max of 53 ml/kg/min for men and 45 ml/kg/min for women on the cycle 
ergometer.  Subjects had to be training a minimum of 7 hours per week on the bike and between 
18 and 40 years old.  During the entire duration of the study, the subjects were required to 
maintain their current volume and intensity of cycling training.  Any potential participants that 
were planning on tapering or vastly increasing volume or intensity of training during the 12 
weeks following the screening appointment were not included in the study.  Subjects completed 
a questionnaire prior to participation to assure they met the inclusion criteria, which included the 
following: must be healthy, non-smoking, and have no history of chronic disease. Consumption 
of anti-inflammatory (Advil, Motrin, etc.) or anti-oxidant supplements (supplemental 
vitamins/minerals, etc.) could not be consumed during the entire testing period.  Subjects must 
have no history of hypertension, history of or current Angiotensin Converting Enzyme (ACE) 
inhibitor use, or use of lipid-lowering, or anti-inflammatory steroid medication; no active weight 
loss > 5 kg in the prior 3 months, and no history of kidney dysfunction.  Subjects must not use 
Selective Serotonin Reuptake Inhibitors (SSRI) during the testing period.  The study was 
conducted under a protocol approved by the University of Texas at Austin Institutional Review 




 This study was a double blind, randomized, placebo controlled, crossover experiment.  
There were 2 testing periods lasting 28 days with a 1 week washout between them.  Preliminary 
testing for determination of each subject’s maximal oxygen consumption (VO2max ) and lactate 
threshold (LT) along with 2 familiarization time trials  (FAM1, FAM2) were performed in a 2 
week period prior to the start of the testing period.  During each testing period, the subject would 
be randomly assigned to ingestion of a daily quercetin based vitamin supplement (Q-VIT) or a 
vitamin supplement without quercetin (VIT).  On the last day of each testing period (Day 28) the 
subject returned to the lab to perform a simulated time trial on a cycle ergometer.  Combined 
with the preliminary testing, there were a total of 6 visits to the Human Performance Laboratory 
for each subject.  The preliminary phase of testing consisted of the first 4 visits:  VO2max testing, 
LT testing, FAM1, and FAM2.  The testing period consisted of 2 visits to the lab in which the 
subjects would perform the simulated time trial on Day 28 of supplementation (TT1 and TT2).  
Data collection during the time trials included gas measurements (VO2 and VCO2), heart rate, 
power output, Borg scale Rating of Perceived Exertion (RPE), and time to completion.  







Maximal Oxygen Consumption (VO2max)  
There was a minimum of 48 hours between each of the preliminary visits.  The first visit 
consisted of the determination of VO2max on an electromagnetically braked cycle ergometer 
(Lode; Gronigen, Netherlands). It was determined by having each subject perform a submaximal 
cycling protocol with 4, 5 min stages at 80, 120, 160 and 200 watts or 100, 140, 160 and 220 
watts.  Following a 10-15 min rest period, each subject performed a VO2max test.  Briefly, the 
first four minute stage was set at a workload to achieve ~75-80% of predicted VO2max based on 
the submaximal heart rate and oxygen consumption vs. workload regression equations and age 
predicted max heart rate (208-0.7*age).  Following the first four-minute stage, the workload was 
increased every 2 minutes until 10 minutes and then increased at 1 min increments thereafter 
until volitional fatigue.  Peak oxygen consumption was determined from the final 30 seconds 
prior to exhaustion during the maximal protocol.  The subjects breathed through a 2 way valve 
while the volume of inspired air was determined by a pnuemotachometer (Hans Rudolph Inc., 
Model 4813; Kansas City, MO).  Expired air entered a mixing chamber and was analyzed for 
oxygen (AEI Technologies, Oxygen Analyzer S-3A/I, Pittsburg, PA) and carbon dioxide (AEI 
Technologies, Carbon Dioxide Analyzer CO-3A, Pittsburg, PA).  The analyzers were connected 
to a computer and computer software was utilized for the output of gas measurements. 
Lactate Threshold (LT) 
 The second visit to the lab consisted of the determination of the subjects lactate threshold 
(LT) on the cycle ergometer.  Each subject completed 5, 5 minute stages of cycling with a 
progressively increasing workload with each stage.  Workload at each stage consisted of 
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wattages meant to elicit 50, 60, 70, 80, and 90 percent of the subjects VO2max.  During the last 
minute of each stage, a small droplet of blood was obtained by pricking the end of the subject’s 
finger and analyzed for blood lactate utilizing a handheld blood lactate test meter (Arkray Inc., 
Lactate Pro, Kyoto, Japan).  LT was defined by graphing the VO2 and lactate relationship and 
determining the  workload that elicited a rise in lactate 1mM above the baseline lactate values as 
previously described by Coyle et al [64].   
Determination of Time Trial Workrate (TTworkrate) 
After determination of the percent VO2max at lactate threshold (% VO2max at LT) and 
subsequent workload that lactate threshold occurred, the workload utilized for the first half of the 
time trial was determined. It was accomplished by calculating the workload that would elicit a 
VO2 10% above the lactate threshold VO2 (TTworkrate).  This was done using the VO2 versus 
workload regression equation determined during the maximal test.  This workrate was utilized to 
pace the participants for the first half of the time trial and has been successfully utilized with 
cyclists within our lab in previous investigations.   
Exercise Trial 
 Upon arrival to the laboratory, subjects were seated and rested for 5 minutes before 
initiation of any measures or activity.  Before and after a 20 minute warmup ride on the cycle 
ergometer at 70% VO2max, subjects were seated and blood was drawn via venipuncture of an 
antecubital vein.  After the second blood draw, the subjects began the exercise time trial on the 
cycle ergometer.  The goal of the time trial was to complete a set amount of work as quickly as 
possible.  The required Kilojoules that the participant needs to complete during the time trial was 
calculated from the equation below: 
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• TTworkrate = watts = Joules/sec 
• Joules/sec X 2400sec = Joules 
• Joules/1000 = Time Trial kJ (TT kJ)  
 
The first 20 minutes of the time trial were set at a fixed workrate equal to the aforementioned 
TTwokrate.  Computer software (Lode Ergometer Manager V 9.1, Lode; Gronigen, Netherlands) 
was used to program the cycle ergometer to have a fixed power (fixed power mode) independent 
of cadence during the first 20minutes.  After the first 20 minutes, the cycle ergometer would 
change to a cadence dependent mode (linear mode).  In this mode, the subjects could increase or 
decrease power output (watts) by increasing or decreasing cadence from a previously established 
preferred cadence or by requesting the investigators to raise the TTworkrate.  Workrate was raised 
or lowered in pre-determined increments equal to 5% of their TTworkrate.  The subjects were told 
when they had completed 60, 70, 80, 90, and 95 percent of the work they must complete and the 
approximate time left until completion at their current power output.  Subjects were verbally 
encouraged at these intervals to complete the time trial as fast as possible.  Time to completion 
was recorded as the total time to complete TT kJ.  The subject would immediately move off of 
the cycle ergometer to a seated position for the final blood draw.   Aside from the pacing 
information, the subjects were blinded from all performance information until participation in the 
study was complete. 
 Gas measurements were collected from minute 10 to 15 and from minute 25 to 30.  
Subjects were instructed on the use of hands to signal to request changes in the workrate during 
the gas collection from minute 25 to 30.  Heart rate (HR) was continuously recorded each second 
during the time trial using a wireless receiver and was recorded using custom programmed 
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software.   Heart rate was averaged for 10 seconds and recorded at minute 10, 15, 20, 25, 30, and 
35.  Borg scale (6 – 20) was ascertained at minute 15, 30, and 35.   
 The caloric expenditure per minute (kcal/min) was calculated [65] and then used to 
calculate the cycling gross efficiency (GE) [66]: 
 Kcal/min = 3.716(VO2) + 1.332(VCO2) 
 GE (%) = (watts/69.7) / (kcal/min) 
 
Blood Collection 
 Blood was taken via venipuncture from an antecubital vein before the warmup, after the 
warmup, and after completion of the time trial.  Whole blood was separated into Vacuum sealed 
tubes (Vacutainer, Franklin Lakes, NJ) containing K2EDTA.  The tubes were centrifuged 
immediately at 1000 g for 15 minutes at 4
o
 C for separation of plasma and red blood cells.  The 
plasma was allocated into micro-centrifuge tubes and stored immediately at -80
o
 C.   
Activity and Diet Control 
 Subjects were asked to refrain from any major changes in exercise training for the 
duration of the study.  Subjects recorded daily training during the first supplementation periods 
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that had to be closely matched during the second treatment period.  All subjects were required to 
refrain from exercise the day before their time trial.   
 Diet was recorded during the 3 days leading up to the time trial during the first treatment 
period.  This diet had to be replicated 3 days prior to the time trial during the second treatment 
period.  A minimum of 2 hours was required between the time trial and the subject’s last meal. 
Supplementation 
Subjects supplemented twice daily with a chewable flavored tablets.  Two tablets were 
ingested in the morning and 2 were ingested in the evening.  The Q-VIT tablets each contained 
250 mg quercetin, 205 mg Vitmain C, and 10 mg Vitamin B3 for a total of 1000 mg/day 
quercetin, 820 mg/day Vitamin C, and 40 mg/day Vitamin B3.  The placebo chews (VIT) 
contained identical vitamin ingredients minus the quercetin.  The placebo chews had a similar 
external appearance and flavor.  On the final day of supplementation, subjects were instructed to 
ingest all 4 of the daily chews 2 hours before the time trial. 
Statistical Analysis 
 Performance time and average power output were analyzed with a paired, two-tailed 
Student’s t-test.  All other performance variables were analyzed with a two-way repeated 
measures ANOVA to analyze interaction of treatment and time.  The criterion for significance 
was set at p< 0.05.  All statistics were calculated with IBM SPSS Statistics software, version 19.   






Time to Complete Simulated Time Trial  
Time to complete the pre-determined amount of kilojoules (kJ) on the cycle ergometer was 
reported in minutes (min).  The time to complete the work on quercetin (Q-VIT) and placebo 
(VIT) was 39.36 ± 0.39 min and 39.61 ± 0.42 min, respectively.  There were no significant 
differences between the treatments (p = 0.47).  (Table 1) 
 
Power Output min 20 – end  
Average power output from minute 20 until the end of the time trial was reported as the average 
watts produced.  The average power output from minute 20 until the completion of the time trial 
on Q-VIT and VIT was 247 ± 11 watts and 251 ± 12 watts, respectively.  There were no 
significant differences between the treatments (p = 0.41).  (Table 2) 
 
Oxygen Consumption (VO2) 
VO2 was measured from minute 10 until 15 and from minute 25 until 30 during the time trials 
and was expressed as liters of oxygen consumed per minute (L/min).  The average oxygen 
consumption for the Q-VIT for minutes 10-15 and 25 – 30 were 3.37 ± 0.15 L/min and 3.44 ± 
0.16, respectively.  The VO2 values for the same data points during the VIT trials were 3.30 ± 
0.14 L/min and 3.38 ± 0.17 L/min. There were no significant differences between the treatments 






Gross Efficiency (GE) 
Gross efficiency was measured from minute 10 until 15 and from minute 25 until 30 during the 
time trial and was expressed as the percent of caloric expenditure that was being used for 
production of power.  The average GE for Q-VIT for minutes 10-15 and 25 – 30 were 20.49 ± 
0.26 % and 19.94 ± 0.33 %, respectively.  The GE values for the same data points during the VIT 
trials were 20.9 ± 0.24 % and 20.37 ± 0.33 %.  The GE at minutes 10 – 15 and minutes 25 – 30 
was significantly higher in VIT compared to Q-VIT (p < .01).  (Figure 2) 
 
Respiratory Exchange Ratio (RER) 
RER (VCO2/VO2) was assessed and averaged from minute 10-15 and from minute 25-30 during 
the time trial.  The average RER from minute 10-15 and minutes 25-30 for Q-VIT was 0.95 ± 0.1 
and 0.93 ± 0.1, respectively.  The RER for the same time points during the VIT time trial were 
0.95 ± 0.1 and 0.94 ± 0.1.  There were no differences between the treatments (p = 0.19).  (Figure 
3) 
 
Heart Rate (HR) 
Heart rate was recorded at minute 10, 15, 20, 25, 30, and 35.  There were no significant 
differences in heart rate between the treatments (p = .51).  There was an overall effect of time on 
heart rate (p < 0.01).  Heart rate at 10 minutes was significantly lower than all other time points 
(p < 0.01).  At 15 minutes, heart rate was significantly higher than at 10 minutes (p < 0.01); 
significantly lower than heart rate at 20 minutes (p = 0.02); and significantly lower than heart 
rate at minutes 25, 30, and 35 (p <.01).  At minute 20, the heart rate was significantly lower than 
minute 35 (p < 0.01).  At minute 25, heart rate was significantly lower than heart rate at minute 
24 
 
35 (p = 0.04).  At minute 30, heart rate was significantly lower than heart rate at minute 35 (p < 
0.01).  (Figure 4) 
 
Rating of Perceived Exertion (RPE) 
RPE was recorded at minute 15, 25 and 30 during the time trial.  The average RPE for VIT at 
minute 15, 25, and 30 were 15.6 ± 0.3, 17.5 ± 0.3, and 18.4 ± 0.3, respectively.  The values for 
Q-VIT at the same time points were 15.1 ± 0.3, 17.4 ± 0.3, and 18.5 ± 0.3, respectively.  There 
were no differences between treatments (p = .39).   (Figure 5)  
 
Plasma Quercetin 
Supplementation with Q-VIT was successful in significantly raising plasma quercetin 
concentration when compared to the VIT treatment.  Q-VIT quercetin plasma concentration was 













Table 1- Time (min) to complete set amount of work 
Subject VIT Q-VIT 
1 37.07 38 
3 39.48 42.17 
4 41.35 39.47 
5 40.27 39.53 
6 39.1 39.15 
7 38.97 38.78 
8 40.55 42.8 
9 37.86 37.75 
11 40.2 39.9 
12 36.98 37.93 
13 39.95 40.03 
16 40.95 40.4 
19 39 39.07 
MEAN 39.36 39.61 
± SEM 0.39 0.42 
        













Subject VIT Q-VIT 
1 305 290 
3 300 264 
4 201 221 
5 282 292 
6 309 308 
7 172 174 
8 199 180 
9 225 226 
11 228 232 
12 289 274 
13 256 255 
16 234 240 
19 258 257 
MEAN 251 247 
















































































































































































The primary finding of this study was the negative effect of quercetin supplementation on 
Gross Efficiency (GE) when cycling in trained cyclists without effecting performance measured 
as the time to complete a set amount of work; therefore, there were no changes in the overall 
performance in the trained cyclists in regards to completion of the time trial.  GE was lowered 
from 20.9 to 20.49% during minutes 10 – 15 and from 20.37 to 19.94% during minutes 25 – 30 
when cyclists were supplemented with the Q-VIT compared to VIT.  The change in gross 
efficiency was driven mostly by the non-significant increase in oxygen consumption seen at 
these time points; oxygen consumption was ~2.1% and ~1.8% higher, respectively. No other 
measured parameters of performance were significantly affected by the treatment.  Our results 
also show that the Q-VIT supplement increased plasma concentrations of quercetin by 81 fold in 
the subjects compared to VIT (p < .01). 
 To our knowledge, this is the first study to show a decrement in gross mechanical 
efficiency in conjunction with supplementation of a quercetin based antioxidant supplement.  
There have been equivocal findings thus far regarding the ergogenic effect of either acute or 
chronic supplementation of quercetin on exercise performance.  Improvements in exercise 
performance with quercetin supplementation have been seen in untrained subjects utilizing only 
1 week [12] or 2 weeks [13] of supplementation.  The results of these studies are difficult to 
associate to the current study as the response of individuals that are not actively exercise training 
may not be comparable.   MacRae et al. found an increased performance on a cycling time trial 
with a quercetin based supplement in trained cyclists when compared to a baseline time trial 
[14].  However, there were no differences between the performance times of the quercetin based 
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supplement versus the same supplement without quercetin (the placebo).  Also, there were 
confounding factors involving the composition of the supplements as they contained caffeine.  
Caffeine has been shown to be a powerful ergogenic aid in regards to aerobic exercise 
performance [57, 58].  However, the supplement with quercetin did exhibit better performance 
compared to the baseline time trial without supplementation when compared to the placebo. 
 There have been previous claims from Dumke et al. that chronic quercetin 
supplementation has no effect on cycling GE [52], but the methods utilized for examining the 
potential ergogenic effects of quercetin on cycling performance were not optimal for assessing 
changes in exercise performance.  In a cross-sectional design, trained cyclists supplemented with 
a quercetin based antioxidant supplement or placebo for 3 weeks and were asked to perform 3 
days of 3 hours of cycling at 57% VO2peak before and after supplementation.  This type of 
exercise bout may not be the optimal design for the examination of cycling performance.  Time 
trials similar to the one utilized in the current study have been validated as reliable and 
reproducible and optimal for the assessment of performance on a cycling ergometer [53].  A 
simulated time trial in which as much work as possible is completed during a set amount of time 
or a set amount of work must be completed as quickly as possible may be a more valid exercise 
performance test: The latter type of design was chosen or the current study.     
 Cureton et al. utilized a time trial in which untrained subjects performed as much work as 
possible in 10 minutes on a cycle ergometer after cycling at 50% VO2peak to investigate the 
effects of chronic quercetin supplementation [49].  There were no differences on any measured 
performance variables including VO2, RER, work completed, and other markers of substrate 
utilization.  The overall conclusion of this study was that chronic supplementation with a 
quercetin based antioxidant supplement was not ergogenic in untrained, recreationally active 
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individuals.  However, an inherent flaw of this study was the varying duration of the 
supplementation period between subjects.  The duration of quercetin supplementation ranged 
from 9 to 16 days.  Although one can debate the veracity of claims that this flaw negates their 
findings, it does question the consistency of the results obtained due to differing exposure to the 
quercetin supplementation.  Their results are in contrast to the findings of the previously 
discussed findings from Nieman et al [13] and Davis et al [12] in which quercetin significantly 
improved the exercise performance of untrained subjects.   
   While the chemical properties of the flavonoid quercetin exhibit astounding and 
repeatable effects in vitro by scavenging free radicals, reducing inflammation [6],  and lowering 
oxidative stress [7, 67], attempts at examining the in vivo antioxidant potential of quercetin 
without focusing on the exercise performance per se, have not elucidated quercetin’s powerful 
antioxidant and anti-inflammatory properties.  Most have found no effect of quercetin 
supplementation on markers of oxidative stress in trained [50, 51, 63] or untrained individuals 
[54, 68].  Only in combination with epigallocatechin 3-gallate (EGCG) has quercetin been shown 
to significantly decrease markers of oxidative stress and inflammation in trained cyclists [44].  
The authors concluded that quercetin must be taken with the appropriate mixtures of vitamins 
and sugars for optimal absorption in the gastrointestinal tract.  Vitamin mixtures are suggested 
for optimal absorption of quercetin in humans [37, 45], such as the form of the supplement 
utilized in this study.  Without a measure of oxidative stress, it cannot be concluded if the 
presently reported decrease in efficiency can be linked to changes in oxidative status. 
 In our study, we have teased out the effect of quercetin itself by using a vitamin mixture 
as the placebo group (VIT) and have shown that the flavonoid quercetin can reduce efficiency of 
exercise.  As mentioned, no other studies have shown these detrimental effects in gross 
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efficiency in trained cyclists or in untrained individuals thus far.  Reasons for our novel finding 
may be due to our strict adherence of screening and selecting only well qualified trained cyclist, 
consistency of the quercetin supplement, type of exercise test utilized, and / or the duration of 
supplementation.   
 Due to the evidence in untrained individuals that quercetin may elicit improvements in 
exercise performance, we hypothesized that supplementation with the powerful antioxidant 
quercetin would improve exercise performance in endurance trained subjects.  However, the 
reduced gross efficiency of the quercetin treatment in the trained cyclists in this study indicate 
that these results may not be comparable to the untrained population.  No claims can be made 
based on our data that the quercetin supplementation was detrimental to performance per se, but 
the efficiency of the energy production during the time trials were reduced by quercetin 
supplementation. 
 Although oxidative stress may cause damage to cellular membranes and increases in 
muscular fatigue, DNA damage, and peroxidation of lipid membranes, it may also be necessary 
in moderate amounts to induce adaptive responses [33].  Trained individuals have been shown to 
have and increased endogenous antioxidant capacity when compared to sedentary controls [32, 
69, 70].  That is, both the acute and chronic exposure to exercise training stimulates cellular 
pathways that can elevate concentrations and activities of superoxide dismutase, catalase, and 
glutathione peroxidase in skeletal muscle [19, 71]. It seems plausible that increased cellular 
concentrations of these antioxidants will reduce the risk of cellular injury, improve performance, 
and delay muscle fatigue.  Exposure to higher levels of oxidative stress has also been shown to 
effect DNA repair enzymes and the subsequent expression of cytoprotective proteins such as 
heat shock proteins[18].  Interestingly, it has been established in vitro that quercetin can inhibit 
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the regulation of heat shock proteins [72-74].  These results were proven in a recent human study 
in which chronic supplementation with quercetin inhibited heat adaptation and worsened 
thermotolerance at the cellular and systemic level [75].   
 It has been suggested that the pathways initiated by oxidative stress are essential for the 
body to produce advantageous adaptations in endogenous antioxidants and cytoprotective 
proteins through the activation of nuclear factor kappa-B (NF-КB) and MAP kinases within the 
muscle cell [28]. There are beneficial endogenous adaptations regarding the protection of cellular 
redox homeostasis that occur following an acute bout of exercise, especially through the 
activation of NF-КB [29, 30].  Blockage of RNS production attenuates up-regulation of 
superoxide dismutase, an important endogenous antioxidant, along with eNOS and iNOS [31].  
Preventing oxidative stress during an exercise bout may prevent the production of an improved 
endogenous protection against oxidative stress.   
 Although the subjects that participated in this study were actively training and competing 
in cycling racing, they were not undertaking any training programs meant to elicit improvements 
in their aerobic capacity.  Rather, the trained cyclists were participating in this study during the 
mid to late portion of the cycling competition season and were required to maintain their fitness 
status constant during their commitment to the study.  Cyclists were typically undergoing 
training to maintain their aerobic capacity rather than vastly increasing volume and intensity of 
training during a period of daily racing competitions.  Perhaps the aforementioned regulation of 
cellular adaptation through ROS and RNS mediated pathways was blunted and the subjects’ 
normal exercise training failed to elicit the same stimulus during the Q-VIT versus the VIT.  The 
longevity of decrement in the exercise stimulus may have caused a maladaptive response to their 
normal training and triggered the decrease in gross efficiency. 
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 In conjunction with the reduction in stimulation of the ROS and RNS mediated 
adaptation pathways, the functioning of the mitochondria and electron transport chain (ETC) 
may have been effected.   The exercise induced oxidative stress may have reduced the efficiency 
of the electron transport chain (ETC) and therefore reduced the efficiency of NADH:NAD
+
 
cycling [25, 26].  In turn, the efficiency of ATP production would have been reduced.  The free 
radicals can also have detrimental effects on the tricarboxylic acid  (TCA) cycle by inhibiting the 
actions of enzymes such as α-ketoglutarate dehydrogenase (KGDH) and succinate 
dehydrogenase (SDH)[27].  It may seem intuitive that the quercetin supplementation should 
improve the efficiency of the ETC by mitigating the detrimental effects of the free radicals on the 
functioning of the ETC; however, chronic supplementation may have caused the down regulation 
of endogenous antioxidant enzymes and actually increased the levels of oxidative stress upon the 
ETC.  In a feedback mechanism, the lowered levels of oxidative stress through quercetin’s 
scavenging of free radicals may have lowered the activation of the ROS and RNS mediated 
pathways of cellular adaptation [28, 33, 71].  Pharmacological studies have also found inverse 
relationships between the concentration of glutathione and the amount of superoxide and 
hydrogen peroxide production [76, 77] which may be a reflection of the events occurring in the 
trained cyclists during the down regulation of their endogenous antioxidant factors. 
 The primary finding of this study was unique in that the reduction in gross efficiency did 
not affect the time to complete the time trial.  It has been well established that cycling gross 
efficiency is a major determinant of cycling performance in well trained and elite cyclists and is 
highly correlated to the amount and functioning of type I muscle fibers [66, 78, 79].  It has also 
been shown that small increments or decrements in cycling efficiency may manifest changes in 
endurance performance [80].  Work from Mogensen et al. [81] has further investigated the 
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mechanisms behind the increased efficiency and their results implied that it may be the result of 
the efficiency of transferring the chemical energy from ATP hydrolysis into physical work rather 
than mitochondrial efficiency [82].  Nevertheless, it is difficult to interpret how this may be 
affected by the evidence that mitochondrial complex I function and hampered cycling of 
NAD:NADH may affect these processes.  The possible down regulation of the endogenous 
antioxidant defenses may contribute to lessened mitochondrial efficiency and / or conversion of 
the energy from ATP hydrolysis into physical work.  However, it can only be speculated from 
our results since no mechanisms involved in this process were directly measured. 
The absolute changes in GE were ~0.42% at both measured timepoints during the time 
trial.  This is not a huge decremement, however it was a statistically significant finding (p <0.01) 
with 17 out of the 20 measured timepoints from all of the subjects exhibited a lower efficiency 
on quercetin supplementation.  The 3 timepoints that did not follow this trend were dispersed 
amongst 3 separate subjects.  This decrement in GE did not elicit any differences between the 
treatments in the performance time of the time trial in the trained subjects.  The trained cyclists 
exhibited higher oxygen consumption while supplementing with quercetin during equivalent 
power output between treatments, although this finding did not reach statistical significance.  In 
essence, the cyclists could maintain equivalent power output, heart rates, and time to complete 
the time trials although the efficiency was slightly lower when taking quercetin. 
One possible explanation is the change in the efficiency was too small to impact their 
performance time during this type of time trial.  Subjects were performing at an average of ~85% 
VO2peak or higher during most of the last half of the time trial.   This very high intensity and 
average duration of ~39.5 minutes may have been too short and of an exercise intensity that is 
too high to elucidate the small change that was seen in the GE.  A longer duration exercise trial 
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of a lesser exercise intensity, such as a time to fatigue test, may have exposed differences in the 
performance times. 
There were limitations that must be realized pertaining to the application of the results of 
this study.  The placebo (VIT) contained Vitamin C and Vitamin B3 in order to expound the 
effects of quercetin itself on the cyclists’ performance, however the effect of the vitamin 
supplementation itself on the exercise performance of the cyclist cannot be determined with this 
design.  It cannot be concluded if the effect of Q-VIT may have been more detrimental to 
performance and / or efficiency compared to their baseline performance variables.   Aside from 
the previously discussed mechanisms in this discussion, readers are directed to more 
comprehensive reviews on vitamin supplementation and exercise performance for a full 
discussion on this still debated topic [83, 84].   
Also, highly elevated quercetin was present in the plasma at the time of the exercise 
performance testing in Q-VIT compared to VIT, therefore it can be difficult to interpret if that 
may have affected the GE.  While there is evidence to support the lack of an ergogenic effect of 
an acute dosage of quercetin on exercise performance [54, 56], it is prudent to claim that it may 
not have affected the performance of the cyclists.     
In conclusion, daily supplementation with the flavonoid quercetin for 28 days lowered 
cycling gross efficiency without affecting the time to complete a time trial in trained cyclists.  
This may be an important finding as the use of antioxidant supplementation in highly trained 
endurance athletes has become a popular method of nutritional augmentation due to the high 
levels of oxidative stress experienced during exercise training.  Although the decrease in gross 
efficiency failed to affect the performance time of the time trial, the exercise bout utilized in this 
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study was short and of a relatively high intensity. Further research is needed to validate and 
examine the mechanisms behind these changes in efficiency.  
 
  


























20-end    Time  
       
Subject 871 532  Subject 871 532 
1 305 290  1 37.07 38 
3 300 264  3 39.48 42.17 
4 201 221  4 41.35 39.47 
5 282 292  5 40.27 39.53 
6 309 308  6 39.1 39.15 
7 172 174  7 38.97 38.78 
8 199 180  8 40.55 42.8 
9 225 226  9 37.86 37.75 
11 228 232  11 40.2 39.9 
12 289 274  12 36.98 37.93 
13 256 255  13 39.95 40.03 
16 234 240  16 40.95 40.4 
19 258 257  19 39 39.07 
Mean 251 247  Mean 39.36 39.61 
± SEM 12 11  ± SEM 0.39 0.42 
 
   Rating of Percieved Exertion   
                      
 VIT    Q-VIT 
Subject 15min 30 min 35 min overall    15min 30 min 35 min overall 
1 14 18 20 20    15 20 20 20 
3 15 17 19 18    16 19 19 18 
4 17 17 18 18    16 18 19 18 
5 17 17 18 19.5    16 18 19 17 
6 15 16 19 17    14 15 18 17 
7 16 19 19.5 18.5    15 18 19 20 
8 15 17 17 18    15 16 16 17 
9 16 19 19 20    16 19 19.5 19.5 
11 17 17 17 17    16 17 18 18 
12 16 18 20 18    17 19 20 19.5 
13 15 17 18 17    15 16 18 16 
16 15 16 16 18    15 16 17 15 
19 14 17 19 20     13 19 19 20 
Mean 15.5 17.3 18.4 18.4    15.3 17.7 18.6 18.1 
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